The Australian Pharmaceutical Market  

Australia’s population of over 24 million is well served by a buoyant and diversified healthcare sector. 

 

IMS ranks Australia as the 12th largest market globally.(Medicines Australia 2015). 

 

Australian operates a government subsidised Pharmaceutical Benefits Scheme (PBS) where patient’s co pay for the cost of their prescriptions. The PBS operate a list of medications and approved suppliers which fall into the scheme generating the industry some $12 billion AUD in sales annually.

Products that are manufactured to target the EU and USA markets maybe able to be supplied to the Australian market.

Pro PG and Logo are registered trademarks owned by Pro Pharmaceuticals Group